Executive stock award: IBEX (IBEX) officer gains 82,519 shares, 12,246 withheld

Rhea-AI Filing Summary

IBEX Ltd’s Chief Sales and CS Officer, Bruce Neil Dawson, reported equity awards and related tax withholding in company stock. On February 6, 2026, he acquired 82,519 common shares at $0 per share as a restricted stock award tied to an April 20, 2022 performance share grant that met revenue and EBITDA targets.

These shares vest in three equal parts: one-third vested on February 6, 2026, with additional thirds scheduled for February 6, 2027 and February 6, 2028, contingent on his continued service. On the same date, 12,246 common shares were disposed of at $34.98 per share to satisfy tax withholding on the vesting. After these transactions, he directly owned 77,034 common shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Dawson Bruce Neil

Role Chief Sales and CS Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	82,519	$0.00	--
Tax Withholding	Common Shares	12,246	$34.98	$428K

Holdings After Transaction: Common Shares — 89,280 shares (Direct)

Footnotes (1)

1. Reporting Person received this restricted stock award in connection with the vesting of an April 20, 2022 performance share award upon the attainment of certain Issuer Revenue and EBITDA targets for the trailing four (4) quarters. One-third of these shares vested on February 6, 2026. The remaining shares will vest one-third on February 6, 2027 and one-third on February 6, 2028. Vesting of performance share awards and shares issued in respect thereof is subject to the Reporting Person's continued service to the Company with Issuer through the applicable vesting date. Represents shares withheld for tax purposes upon vesting of restricted stock grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dawson Bruce Neil

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales and CS Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/06/2026		A		82,519	A	$0(1)	89,280	D
Common Shares	02/06/2026		F		12,246(2)	D	$34.98	77,034	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reporting Person received this restricted stock award in connection with the vesting of an April 20, 2022 performance share award upon the attainment of certain Issuer Revenue and EBITDA targets for the trailing four (4) quarters. One-third of these shares vested on February 6, 2026. The remaining shares will vest one-third on February 6, 2027 and one-third on February 6, 2028. Vesting of performance share awards and shares issued in respect thereof is subject to the Reporting Person's continued service to the Company with Issuer through the applicable vesting date.

2. Represents shares withheld for tax purposes upon vesting of restricted stock grant.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IBEX (IBEX) report for Bruce Neil Dawson?

IBEX reported that Chief Sales and CS Officer Bruce Neil Dawson received 82,519 common shares as a restricted stock award, with part vesting on February 6, 2026, and sold 12,246 shares to cover related tax withholding obligations.

How many IBEX common shares did Bruce Neil Dawson acquire on February 6, 2026?

He acquired 82,519 IBEX common shares on February 6, 2026 as a restricted stock award. This award was earned after meeting revenue and EBITDA targets under an April 20, 2022 performance share agreement.

Why were 12,246 IBEX shares disposed of in Dawson’s Form 4 filing?

The 12,246 IBEX shares were disposed of to cover tax withholding obligations related to the vesting of Dawson’s restricted stock grant. The disposition was reported at a price of $34.98 per share in the non-derivative securities table.

What performance conditions triggered Bruce Neil Dawson’s IBEX stock award?

The restricted stock award was triggered by achieving specified IBEX revenue and EBITDA targets over the trailing four quarters, tied to an April 20, 2022 performance share award. Meeting these targets caused a portion of those performance shares to vest as common stock.

How is Bruce Neil Dawson’s IBEX stock award scheduled to vest?

The award vests in three equal installments: one-third vested on February 6, 2026, with additional one-third tranches scheduled for February 6, 2027 and February 6, 2028, contingent on Dawson’s continued service with IBEX through each vesting date.

How many IBEX shares does Bruce Neil Dawson own after the reported transactions?

After the reported acquisition and tax-withholding disposition, Bruce Neil Dawson directly owned 77,034 IBEX common shares. This figure is listed as his beneficially owned balance following the February 6, 2026 non-derivative transactions.